Edesa Biotech, Inc. (EDSA) Earnings History
Net Loss17 years of earnings data (2009–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Edesa Biotech, Inc. (EDSA) Earnings Overview
As of June 12, 2026, Edesa Biotech, Inc. (EDSA) reported trailing twelve-month net income of -$10M, reflecting +34.2% year-over-year growth. The company earned $-1.27 per diluted share over the past four quarters.
Looking at the long-term picture, EDSA's historical earnings data spans multiple years. The company achieved its highest annual net income of -$73,917 in fiscal 2009.
Edesa Biotech, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including ADMA ($165M net income, 28.8% margin), NUVB (-$146M net income, -325.3% margin), HALO ($349M net income, 22.7% margin), EDSA has comparable earnings metrics. Compare EDSA vs ADMA →
EDSA Earnings vs Peers
Earnings metrics vs comparable public companies
EDSA Historical Earnings Data (2009–2025)
17 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$7M | -16.5% | -$8M | $-1.27 | - | - |
| 2024 | -$6M | +26.3% | -$7M | $-1.93 | - | - |
| 2023 | -$8M | +52.3% | -$9M | $-2.93 | - | - |
| 2022 | -$18M | -31.5% | -$18M | $-8.37 | - | - |
| 2021 | -$13M | -109.7% | -$24M | $-7.73 | - | - |
| 2020 | -$6M | -133.9% | -$6M | $-5.18 | -1935.6% | -1946.7% |
| 2019 | -$3M | +46.0% | -$3M | $-4.15 | -662.3% | -689.3% |
| 2018 | -$5M | -0.2% | -$5M | $-10.54 | -2378.6% | -2397.1% |
| 2017 | -$5M | -0.1% | -$5M | $-211.28 | -2203.7% | -2288.6% |
| 2016 | -$5M | -76.8% | -$5M | $-23.92 | -395.2% | -386.0% |
| 2015 | -$3M | +66.3% | -$4M | $-15.01 | -374.7% | -571.9% |
| 2014 | -$8M | +43.3% | -$6M | $-46.75 | -2267.9% | -1536.7% |
| 2013 | -$15M | -186.5% | -$4M | $-121.14 | -2729.1% | -674.4% |
| 2012 | -$5M | +26.7% | -$7M | $-49.86 | -1816.7% | -2280.2% |
| 2011 | -$7M | -1101.1% | -$7M | $-78.14 | -1016.4% | -1018.4% |
| 2010 | $-589,971 | -698.2% | -$1M | $-15.88 | -69.0% | -124.6% |
| 2009 | $-73,917 | - | $-78,557 | $-7.67 | - | - |
Download Data
Export EDSA earnings history in CSV or JSON format
Free sign-in required to download data
What if you invested $1,000 in EDSA back in 2009?
Total return with dividends reinvested · 17+ years of data
Calculate ReturnsHow much would $100/month in EDSA be worth today?
Dollar cost averaging vs lump sum · see how regular investing compounds over time
Run the NumbersIs EDSA Undervalued Right Now?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationEDSA vs LLY — which is the better buy?
Side-by-side revenue, margins, P/E and 10-year returns vs Eli Lilly and Company.
Compare NowEDSA — Frequently Asked Questions
Quick answers to the most common questions about buying EDSA stock.
What is EDSA earnings per share (EPS)?
EDSA trailing twelve-month (TTM) diluted EPS is $-1.27, reflecting +34.2% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2009 to 2025 is available in the table on this page.
What is Edesa Biotech, Inc.'s net income?
Edesa Biotech, Inc. (EDSA) trailing twelve-month net income is $-10M as of 2025. Earnings grew +34.2% year-over-year.
Is EDSA profitable?
EDSA is not currently profitable on a TTM basis, reporting a net loss of $-10M. Net margin is N/A. Investors should monitor for a return to profitability.
What is EDSA's earnings growth rate?
EDSA compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2009 to 2025.
What are EDSA's profit margins?
Edesa Biotech, Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -99.6%.
Is EDSA growing earnings?
Yes, EDSA earnings are accelerating — EPS growth of +34.2% exceeds the 5-year CAGR of N/A. TTM net income reached $-10M. Earnings momentum is strengthening.
What was EDSA's best earnings year?
Edesa Biotech, Inc.'s highest annual net income on record is $-73917.00, achieved in fiscal year 2009. Earnings history on this page spans 2009 to 2025 and includes all annual and quarterly figures.
What were EDSA's earnings last quarter?
EDSA's most recent reported quarter was Q2 2026. Net income was $-4M with diluted EPS of $-0.50. For a full breakdown of all quarters, see the quarterly earnings table on this page.